Expression of Zinc Finger and BTB Domain-Containing 4 in Colorectal Cancer and Its Clinical Significance
Authors:
Open Access
- 1 October 2020
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 9621-9626
Abstract
Background: Zinc finger and BTB domain-containing 4 (ZBTB4), which is a transcriptional regulator, has been identified as a tumor suppressor in several human carcinomas. So far, however, the expression of ZBTB4 and its possible clinical significance in colorectal cancer (CRC) remain unknown. Materials and Methods: The mRNA and protein expressions of ZBTB4 in five CRC cell lines were respectively detected by performing qRT-PCR and Western Blotting. ZBTB4 expression in colorectal tissue specimens was determined, and subsequently its relationship with clinical prognosis was examined. Results: The mRNA and protein expressions of ZBTB4 were significantly decreased in all the five CRC cell lines compared with normal colonic epithelial cells. Consistent with the cell data, immunohistochemical results showed that as compared with the normal colorectal tissue samples, ZBTB4 protein expression was clearly lower in the CRC tissue samples, especially in CRC patients with liver metastasis. In addition, low-expressed ZBTB4 was found associated with tumor metastasis stage (P=0.0003) and level of carcinoembryonic antigen (CEA) (P=0.0004). The overall survival (OS) and recurrence-free survival (RFS) in the ZBTB4-low group were significantly lower than those in the ZBTB4-high group (P=0.0007 and P=0.0077). Conclusion: The current findings showed that patients with high-expressed ZBTB4 in CRC tissues may develop a better prognosis, and ZBTB4 could serve as a potential therapeutic target for CRC treatment.Keywords
This publication has 16 references indexed in Scilit:
- Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studyEBioMedicine, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- The Transcriptional Repressor ZBTB4 Regulates EZH2 Through a MicroRNA-ZBTB4-Specificity Protein Signaling AxisNeoplasia, 2014
- Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 ClustersMolecular Cancer Therapeutics, 2012
- Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancerOncogene, 2011
- The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4Oncogene, 2009
- Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activationThe EMBO Journal, 2008
- Cancer Metastasis: Building a FrameworkCell, 2006
- Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2006
- A role for Kaiso–p120ctn complexes in cancer?Nature Reviews Cancer, 2005